Patent ID: 11883427
Assignee: PHARAGEN LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating acid reflux disease selected from the group consisting of laryngopharyngeal reflux and erosive esophagitis, comprising administering to an individual in need thereof a pharmaceutical composition comprising:
(i) one or more alginate salts, present in an amount from about 100 mg to 2,000 mg,
(ii) sodium bicarbonate, present in an amount from about 1 mg to 100 mg,
(iii) a calcium composition, present in an amount from about 40 mg to 60 mg,
(iv) optionally one or more natural or artificial sweetener or flavorants, present in an amount from about 1.0 mg to 10,000 mg, and
wherein the pharmaceutical composition is formulated as a powder or capsule form prior to dissolution, and when dissolved in a liquid the composition forms an alginate raft prior to administration to an individual.